Lantern Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Lantern Pharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- LTRN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001763950
Board of directors
-
D. Jeffrey Keyser · DirectorSince 2024
-
David S. Silberstein · DirectorSince 2024
-
Lee Troy Schalop · DirectorSince 2025
-
Maria-Luisa Maccecchini · DirectorSince 2024
-
Panna Sharma · Director · President & CEOSince 2024
-
Vijay Chandru · DirectorSince 2024
Chief executives
Panna Sharma
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Maria-Luisa Maccecchini
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $200,001
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 12, 2026 | Lee Troy Schalop Director | Open-market purchase | +48,544 | $2.06 | $100,001 |
| May 12, 2026 | D. Jeffrey Keyser Director | Open-market purchase | +48,544 | $2.06 | $100,001 |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | Open-market sale | −7,206 | $3.09 | $22,267 |
| Jun 13, 2025 | BP Directors, LP 10% owner | Open-market sale | −7,206 | $3.09 | $22,267 |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | Open-market sale | −12,319 | $3.09 | $38,066 |
| Jun 13, 2025 | BP Directors, LP 10% owner | Open-market sale | −12,319 | $3.09 | $38,066 |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | Open-market sale | −1,903 | $3.09 | $5,880 |
| Jun 13, 2025 | BP Directors, LP 10% owner | Open-market sale | −1,903 | $3.09 | $5,880 |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | Open-market sale | −14,218 | $3.09 | $43,934 |
| Jun 13, 2025 | BP Directors, LP 10% owner | Open-market sale | −14,218 | $3.09 | $43,934 |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | Open-market sale | −4,354 | $3.09 | $13,454 |
| Jun 13, 2025 | BP Directors, LP 10% owner | Open-market sale | −4,354 | $3.09 | $13,454 |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | Open-market sale | −10,925 | $3.38 | $36,927 |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | Open-market sale | −10,925 | $3.38 | $36,927 |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | Open-market sale | −18,678 | $3.38 | $63,132 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.